Multiple Ras downstream pathways mediate functional repression of the homeobox gene product TTF-1

Molecular and Cellular Biology

Volumn 20, Issue 8, 2000, Pages 2783-2793

  Missero, Caterina ^a   Pirro, Maria Teresa ^a   Di Lauro, Roberto ^a  

^a STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENZYME INHIBITOR; HOMEODOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TTF 1; RAC PROTEIN; RAF PROTEIN; RAS PROTEIN; RHO FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; GENE REPRESSION; HOMEOBOX; HUMAN; HUMAN CELL; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; THYROID GLAND; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; GENES, RAS; HOMEODOMAIN PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; RATS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; THYROID GLAND; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0034079564     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.8.2783-2793.2000     Document Type: Article

References (65)

1. Akasaka, K., M. Tamada, F. Wang, K. Kariya, F. Shima, A. Kikuchi, M. Yamamoto, M. Shirouzu, S. Yokoyama, and T. Kataoka. 1996. Differential structural requirements for interaction of Ras protein with its distinct downstream effectors. J. Biol. Chem. 271:5353-5360.
2. Ambesi-Impiombato, F. S., L. A. M. Parks, and H. G. Coon. 1980. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc. Natl. Acad. Sci. USA 77:3455-3459.
3. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
4. Bos, J. L. 1988. The ras gene family and human carcinogenesis. Mutat. Res. 195:255-271.
5. Brasier, A. R., J. E. Tate, and J. F. Habener. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7:1116-1122.
6. Campbell, S. L, R. Khosravi-Far, K. L. Rossman, G. J. Clark, and C. J. Der. 1998. Increasing complexity of Ras signaling. Oncogene 17:1395-1413.
7. Choi, C. Y., Y. M. Lee, Y. H. Kim, T. Park, B. H. Jeon, R. A. Schulz, and Y. Kim. 1999. The homeodomain transcription factor NK-4 acts as either a transcriptional activator or repressor and interacts with the p300 coactivator and the groucho corepressor. J. Biol. Chem. 274:31543-31552.
8. Civitareale, D., M. P. Castelli, P. Falasca, and A. Saiardi. 1993. Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. Mol. Endocrinol. 7:1589-1595.
9. Civitareale, D., R. Lonigro, A. J. Sinclair, and R. Di Lauro. 1989. A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J. 8:2537-2542.
10. Cobellis, G., C. Missero, and R. Di Lauro. 1998. Concomitant activation of MEK-1 and Rac-1 increases the proliferative potential of thyroid epithelial cells, without affecting their differentiation. Oncogene 17:2047-2057.
11. Coso, O. A., M. Chiariello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137-1146.
12. Davis, R. J. 1995. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42:459-467.
13. De Felice, M., G. Damante, M. Zannini, H. Francis-Lang, and R. Di Lauro. 1995. Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1. J. Biol. Chem. 270:26649-26656.
14. Downward, J. 1996. Control of ras activation. Cancer Surv. 27:87-100.
15. Endo, T., M. Kaneshige, M. Nakazato, M. Ohmori, N. Harii, and T. Onaya. 1997. Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/I-symporter gene. Mol. Endocrinol. 11:1747-1755.
16. Farid, N. R., Y. Shi, and M. Zou. 1994. Molecular basis of thyroid cancer, Endocr. Rev. 15:202-232.
17. Francis-Lang, H., M. Price, M. Polycarpou-Schwarz, and R. Di Lauro. 1992. Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol. Cell. Biol. 12:576-588.
18. Francis-Lang, H., M. Zannini, M. De Felice, M. T. Berlingieri, A. Fusco, and R. Di Lauro. 1992. Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol. Cell. Biol. 12:5793-5800.
19. Fusco, A., M. T. Berlingieri, P. P. Di Fiore, G. Portella, M. Grieco, and G. Vecchio. 1987. One-and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol. Cell. Biol. 7:3365-3370.
20. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, and P. E. Shaw. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14:951-962.
21. Guazzi, S., M. Price, M. De Felice, G. Damante, M. G. Mattei, and R. Di Lauro. 1990. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J. 9:3631-3639.
22. Hofer, F., S. Fields, C. Schneider, and G. S. Martin. 1994. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Natl. Acad. Sci. USA 91:11089-11093.
23. Hu, E., J. B. Kim, P. Sarraf, and B. M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103.
24. Jaaro, H., H. Rubinfeld, T. Hanoch, and R. Seger. 1997. Nuclear translocation of mitogen-activatcd protein kinase kinase (MEKI) in response to mitogenic stimulation. Proc. Natl. Acad. Sci. USA 94:3742-3747.
25. Joneson, T., and D. Bar-Sagi. 1997. Ras effectors and their role in mitogenesis and oncogenesis. J. Mol. Med. 75:587-593.
26. Joneson, T., M. A. White, M. H. Wigler, and D. Bar-Sagi. 1996. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271:810-812.
27. Karga, H., J. K. Lee, A. L. Vickery, Jr., A. Thor, R. D. Gaz, and J. L. Jameson. 1991. Ras oncogene mutations in benign and malignant thyroid neoplasms. J. Clin. Endocrinol. Metab. 73:832-836.
28. Katz, M. E., and F. McCormick. 1997. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7:75-79.
29. Khosravi-Far, R., M. A. While, J. K. Westwick, P. A. Solski, M. Chrzanowska-Wodnicka, L. Van Aelst, M. H. Wigler, and C. J. Der. 1996. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16:3923-3933.
30. Kikuchi, A., S. D. Demo, Z.-H. Ye, Y.-W. Chen, and L. T. Williams. 1994. ralGDS family members interact with the effector loop of ras p21. Mol. Cell. Biol. 14:7483-7491.
31. Kimura, S., Y. Hara, T. Pineau, P. Fernandez-Salguero, C. H. Fox, J. M. Ward, and F. J. Gonzalez. 1996. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 10:60-69.
32. Kong, Y., S. E. Johnson, E. J. Taparowsky, and S. F. Konieczny. 1995. Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol. Cell. Biol. 15:5205-5213.
33. Kupperman, E., D. Wofford, W. Wen, and J. L. Meinkoth. 1996. Ras inhibits thyroglobulin expression but not cyclic adenosine monophosphate-mediated signaling in Wistar rat thyrocytes. Endocrinology 137:96-104.
34. Lange-Carter, C. A., C. M. Pleiman, A. M. Gardner, K. J. Blumer, and G. L. Johnson. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260:315-319.
35. Lazzaro, D., M. Price, M. de Felice, and R. Di Lauro. 1991. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113:1093-1104.
36. Lowy, D. R., and B. M. Willumsen. 1993. Function and regulation of ras. Annu. Rev. Biochem. 62:851-891.
37. Marais, R., and C. J. Marshall. 1996. Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 27:101-125.
38. Masuda, T., K. Kariya, M. Shinkai, T. Okada, and T. Kataoka. 1995. Protein kinase Byr2 is a target of Ras1 in the fission yeast Schizosaccharomyces pombe. J. Biol. Chem. 270:1979-1982.
39. Miller, M. J., S. Prigent, E. Kupperman, L. Rioux, S. H. Park, J. R. Feramisco, M. A. White, J. L. Rutkowski, and J. L. Meinkoth. 1997. RalGDS functions in Ras- and cAMP-mediated growth stimulation. J. Biol. Chem. 272:5600-5605.
40. Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157.
41. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723.
42. Missero, C., G. Cobellis, M. De Felice, and R. Di Lauro. 1998. Molecular events involved in differentiation of thyroid follicular cells. Mol. Cell. Endocrinol. 140:37-43.
43. Morrison, D. K., and R. E. Cutler. 1997. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9:174-179.
44. Ohno, M., M. Zannini, O. Levy, N. Carrasco, and R. Di Lauro. 1999. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol. Cell. Biol. 19:2051-2060.
45. Qiu, R. G., J. Chen, D. Kirn, F. McCormick, and M. Symons. 1995. An essential role for Rac in Ras transformation. Nature 374:457-459.
46. Qiu, R. G., J. Chen, F. McCormick, and M. Symons. 1995. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92:11781-11785.
47. Rameh, L. E., and L. C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:8347-8350.
48. Ridley, A. J., H. F. Paterson, C. L. Johnston, D. Diekmann, and A. Hall. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410.
49. Rodriguez-Viciana, P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527-532.
50. Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phospho-inositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
51. Schnabel, C. A., and C. Abate-Shen. 1996. Repression by HoxA7 is mediated by the homeodomain and the modulatory action of its N-terminal-arm residues. Mol. Cell. Biol. 16:2678-2688.
52. Shirouzu, M., H. Koide, J. Fujita-Yoshigaki, H. Oshio, Y. Toyama, K. Yamasaki, S. A. Fuhrman, E. Villafranca, Y. Kaziro, and S. Yokoyama. 1994. Mutations that abolish the ability of Ha-Ras to associate with Raf-1. Oncogene 9:2153-2157.
53. Songyang, Z., K. P. Lu, Y. T. Kwon, L. H. Tsai, O. Filhol, C. Cochet, D. A. Brickey, T. R. Soderling, C. Bartleson, D. J. Graves, A. J. DeMaggio, M. F. Hoekstra, J. Blenis, T. Hunter, and L. C. Cantley. 1996. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16:6486-6493.
54. Suarez, H. G. 1998. Genetic alterations in human epithelial thyroid tumours. Clin. Endocrinol. 48:531-546.
55. Urano, T., R. Emkey, and L. A. Feig. 1996. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 15:810-816.
56. Van Aelst, L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213-6217.
57. White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80:533-541.
58. White, M. A., T. Vale, J. H. Camonis, E. Schaefer, and M. H. Wigler. 1996. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 271:16439-16442.
59. Whitmarsh, A. J., and R. J. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:589-607.
60. Winkler, D. G., J. C. Johnson, J. A. Cooper, and A. B. Vojtek. 1997. Identification and characterization of mutations in Ha-Ras that selectively decrease binding to cRaf-1. J. Biol. Chem. 272:24402-24409.
61. Wolthuis, R. M., B. Bauer, L. J. van't Veer, A. M. de Vries-Smits, R. H. Cool, M. Spaargaren, A. Wittinghofer, B. M. Burgering, and J. L. Bos. 1996. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene 13:353-362.
62. Yuryev, A., and L. P. Wennogle. 1998. The RAF family: an expanding network of post-translational controls and protein-protein interactions. Cell Res. 8:81-98.
63. Zannini, M., A. Acebron, M. De Felice, M. I. Arnone, J. Martin-Perez, P. Santisteban, and R. Di Lauro. 1996. Mapping and functional role of phosphorylation sites in the thyroid transcription factor-1 (TTF-1). J. Biol. Chem. 271:2249-2254.
64. Zhang, H., K. M. Catron, and C. Abate-Shen. 1996. A role for the Msx-1 homeodomain in transcriptional regulation: residues in the N-terminal arm mediate TATA binding protein interaction and transcriptional repression. Proc. Natl. Acad. Sci. USA 93:1764-1769.
65. Zhang, X. F., J. Settleman, J. M. Kyriakis, E. Takeuchi-Suzuki, S. J. Elledge, M. S. Marshall, J. T. Bruder, U. R. Rapp, and J. Avruch. 1993. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364:308-313.